1. The effect of lycopene on hepatotoxicity of aflatoxin B1 in rats.
- Author
-
Karaca A, Yilmaz S, Kaya E, and Altun S
- Subjects
- Animals, Rats, Male, Rats, Wistar, Alanine Transaminase metabolism, Alanine Transaminase blood, Aspartate Aminotransferases metabolism, Aspartate Aminotransferases blood, Oxidative Stress drug effects, L-Lactate Dehydrogenase metabolism, Carotenoids pharmacology, Lipid Peroxidation drug effects, Lycopene pharmacology, Aflatoxin B1 toxicity, Aflatoxin B1 antagonists & inhibitors, Liver drug effects, Liver metabolism, Antioxidants pharmacology, Glutathione metabolism, Chemical and Drug Induced Liver Injury metabolism, Chemical and Drug Induced Liver Injury prevention & control, Chemical and Drug Induced Liver Injury drug therapy, Malondialdehyde metabolism
- Abstract
Oxidative damage caused by aflatoxin (AF) in rat liver tissue and the inhibition effect of lycopene against this injury was investigated. Groups were formed as; control group (not treated), lycopene group (5 mg/kg/day, gavage for 15 days), AFB1 group (0.5 mg/kg/day, gavage for 7 days) and AFB1 + lycopene group. Lycopene administered simultaneously with AFB1. It was observed significant increase in malondialdehyde level, decrease in glutathione level, antioxidant enzyme activities in liver tissue of AFB1 group when compared with control group. It was determined to significantly increase in plasma aspartate transaminase, alanine transaminase, lactate dehydrogenase activities in AFB1 group when compared with control group. It was determined significant decrease in malondialdehyde level, plasma aspartate transaminase, alanine transaminase, lactate dehydrogenase activities and increase in glutathione level, antioxidant enzyme activities in AFB1 + lycopene group when compared with AFB1 group. This study suggests that lycopene which has antioxidant properties can be prevented from AFB1 induced hepatotoxicity.
- Published
- 2021
- Full Text
- View/download PDF